Acasă

Menarini Group signs licensing deal with Insilico for promising cancer treatment

Mădălina Grigore

InSilico Medicine Jan 10 2025 The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients, and Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, today announced that the companies have entered into an exclusive licensing

din zilele anterioare

Menarini Group signs licensing deal with Insilico for promising cancer treatment https://www.news-medical.net - 10.01.2025 06:06
STIRILE OREI
IN FOCUS: ‘When I die, who’s going to look after you?’ – the pains of caring for adults with disabilities https://www.channelnewsasia.com/ - 06:00
IN FOCUS: ‘When I die, who’s going to look after you?’ – the pains of caring for adults with disabilities https://www.channelnewsasia.com - 06:00
IN FOCUS: ‘I only wish to live one second longer’ – the pains of parents of adults with disabilities https://www.channelnewsasia.com/ - 06:00
IN FOCUS: ‘I only wish to live one second longer’ – the pains of parents of adults with disabilities https://www.channelnewsasia.com - 06:00
Marc Grosjean revient sur ses passages au RFC Liège et au RWDM : "Le FC Liège m'intéresse plus que le RWDM" https://www.dhnet.be/ - 14:53
© Copyright 2017 Mediafax SA | Termeni și condiţii | About cookies | Confidentialitate

monitoruldestiri@mediafax.ro

Fotografiile folosite de monitoruldestiri.ro sunt proprietatea Mediafax. Este interzisă republicarea acestora în lipsa unui acord din partea Mediafax. Pentru a obține acest acord, vă rugăm să ne contactați.